The RegMed Capital Conference (RMCC) in West Palm Beach, Florida, December 6-9, is a co-located meeting at the World Stem Cell Summit. It is an event fully committed to advancing commercialization and investment opportunities for companies targeting cures. Spurred by the unprecedented convergence of 21st Century technologies, the RMCC supplies you with the critical information you need to understand the unlimited potential of regenerative medicine, immunotherapy, cell therapies, and related industries.
RMCC attracts NEW MONEY to our field and provides actionable intelligence supporting both industry and the investment communities.
Investor presentations showcased new developments and clinical trial results. RMCC introduced executives to a qualified audience of investment bankers, venture capitalists, and angel capital investors.
2015 Presenting companies included:
- Bell BIOSYSTEMS
- BioLeonhardt Myo-Stem
- Cellular BioMedicine
- Harvard Apparatus
- Neural Stem Cell Institute
- RegenMed Systems
- Rooster Bio
RMCC answers the tough questions and provides solutions. Preeminent experts shared their plans, best practices, strategic advice, investor insights, non-dilutive funding opportunities, economic development incentives, and other vital information.
Successfully invest. Private investors had an unprecedented opportunity to interact with industry leaders and top Wall Street analysts and the financial media.
Here is a sampling of noted investment banks, venture firms, and angel-networks committed to the RMCC program:
- Excel Venture Management, LLC
- Keiretsu Forum (largest network of accredited investors)
- Livingston Securities LLC
- MEDTOWN Ventures
- Piper Jaffray
- Proteus Venture Partners
- Raymond James & Associates
- WBB Securities
RegMed Capital Conference registration includes full access to the World Stem Cell Summit program.
2015 FEATURED SPEAKERS
Connie Koch Harrell
Keiretsu Forum Southern California, LLA